← Open Payments lookup

EMILY WILLIAMS: Open Payments

NPI 1881790913 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,173 in 91 payments from 16 companies in 2025. Trend: 2023 $1,953 · 2024 $1,964 · 2025 $2,173

Food & beverage: $2,106Education: $67
CompanyPaymentsAmount
GlaxoSmithKline, LLC.23$473
AstraZeneca Pharmaceuticals LP16$389
Regeneron Healthcare Solutions, Inc.15$386
GENZYME CORPORATION10$290
Novartis Pharmaceuticals Corporation6$130
Genentech USA, Inc.4$117
CSL Behring4$110
Takeda Pharmaceuticals U.S.A., Inc.3$62
ARS Pharmaceuticals Operations, Inc.2$46
BioCryst US Sales Co., LLC2$35

Products named: DUPIXENT, TRELEGY ELLIPTA, Xolair, NUCALA, AIRSUPRA, BREZTRI, FASENRA, TEZSPIRE.

Industry payments across TX — which companies pay providers there.